• Read the 2014 Ruesch Center Annual Report

    Updates in molecular medicine, translational research and patient-centered care

    Learn More
  • Explore Our Clinical Trials

    Learn More
  • Explore the Ruesch Center Clinical Partners

    Learn More
  • Medscape: Marshall on Oncology

    Learn More
  • Meet the Nurse Navigators

    Learn how nurse navigators can play an integral role in the delivery of your cancer care

    Learn More
  • A Story of Optimism

    "I'm an optimist by nature so my advice to anybody would be to 'be an optimist.' And I don't mean an optimist if you have cancer – I mean, just be an optimist in life." - Eric Alder

    Learn More

         

NEWS

Ruesch Center Oncologists Interviewed in Medscape's "Advances in GI Cancer: 2014"
December 19th, 2014

Commentary on the latest advances in Gastric Cancer, Gastrointestinal Stromal Tumors, Pancreatic Cancer, Hepatocellular Carcinoma and Colorectal Cancer  Learn More


Medscape Coverage of the Ruesch Symposium - Immunotherapy for GI Cancers: 'More Work to Be Done'
December 12th, 2014

There has been some resistance to the idea of immunotherapy for gastrointestinal cancers. Although early clinical trials have shown clear benefits in patients with pancreatic gastric and colorectal cancers, it "has not been at the same percentage, if you will, as has been seen in the low-lying fruit—kidney cancer, melanoma, and lung cancer," John Marshall, MD told Medscape Medical News.  Learn More


Ruesch Center Symposium - Fighting a Smarter War on Cancer
December 1st, 2014

The 2014 Ruesch Center Symposium, December 4,5 &6!  Day 1 and 2 will present in-depth updates on research and care of GI cancer patients from some of the nations leading GI experts, including the Ruesch medical oncology team.  Day 3 is will be our Patient Symposium which will provide disease-specific information and education to help patients better understand their cancer care. See the Recap Here


 

Dr. Marshall Explains Biomarker Testing in Colorectal Cancer Patients
October 21st, 2014

Biomarker tests help determine which drugs will and will not work. All stage IV colon and rectal cancer survivors should receive KRAS testing. Hear the story of John, a stage IV colon cancer survivor Learn More


 

The Promise and Perils of Genomic Medicine
September 1st, 2014

Kevin Fitzgerald, SJ, PhD, an associate professor at Georgetown Lombardi Cancer Center and the Dr. David P. Lauler Chair for Catholic Health Care Ethics, touches on the ethical issues in personalized medicine, pharmacogenomics, human cloning research, stem cell research, and genetic testing. Learn More